Forte Biosciences (FBRX) Operating Margin (2017 - 2019)
Forte Biosciences (FBRX) reported Operating Margin of 17377.78% for Q4 2019, up 19493333.0% year-over-year from N/an in Q4 2018, and down 128.65% quarter-over-quarter from 7600.0% in Q3 2019.
Forte Biosciences (FBRX) Operating Margin (2017 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has 3 years of Operating Margin data on file, last reported at 17377.78% in Q4 2019.
- Operating Margin for Q4 2019 came in at 17377.78%, up 19493333.0% year-over-year; the trailing twelve-month figure through Dec 2019 was 54855.56% (down 5460132.0% YoY), and the FY2019 annual result was 11288.89%, down 1103466.0% from the prior year.
- Operating Margin eased to 17377.78% in Q4 2019 per FBRX's latest filing, from 7600.0% in the prior quarter.
- Over five years, Operating Margin peaked at 7.92% in Q3 2018 and troughed at 212311.11% in Q4 2018.
- A 3-year average of 94138.07% and a median of 97370.0% in 2017 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2018 and 2019: Operating Margin tumbled 10544111 bps in 2018, then surged 19493333 bps in 2019.
- A 3-year view of Operating Margin shows it stood at 106870.0% in 2017, then slumped by 99 bps to 212311.11% in 2018, then surged by 92 bps to 17377.78% in 2019.
- Business Quant data shows FBRX's Operating Margin at 17377.78% in Q4 2019, 7600.0% in Q3 2019, and 6988.89% in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -17,377.78% |
| Sep 30, 2019 | -7,600.00% |
| Jun 30, 2019 | -6,988.89% |
| Mar 31, 2019 | -187,455.56% |
| Dec 31, 2018 | -212,311.11% |
| Sep 30, 2018 | 7.92% |
| Jun 30, 2018 | -170,300.00% |
| Mar 31, 2018 | -142,733.33% |
| Dec 31, 2017 | -106,870.00% |
| Sep 30, 2017 | -97,370.00% |
| Jun 30, 2017 | -86,520.00% |